According to MedCap's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.70. At the end of 2024 the company had a P/S ratio of 4.73.
Year | P/S ratio | Change |
---|---|---|
2024 | 4.73 | 44.06% |
2023 | 3.29 | 16.21% |
2022 | 2.83 | 1.4% |
2021 | 2.79 | -39.43% |
2020 | 4.60 | 85.36% |
2019 | 2.48 | 68.68% |
2018 | 1.47 | 24.93% |
2017 | 1.18 | 173.06% |
2016 | 0.4317 | 14.11% |
2015 | 0.3783 | -12.63% |
2014 | 0.4331 | -51.47% |
2013 | 0.8923 | 31.72% |
2012 | 0.6774 | 24.63% |
2011 | 0.5435 | -10.84% |
2010 | 0.6097 | 17.66% |
2009 | 0.5182 |